Email this article 
Treatment policy for localized oral cancer
- Authors: Gel’fand I.M.1,2, Romanov I.S.1,2, Udintsov D.B.1,2
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center at the Ministry of Health of Russia
- 24 Kashirskoe Shosse, Moscow, 115478, Russia
- Issue: Vol 6, No 1 (2016)
- Pages: 43-45
- Section: DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
- Published: 30.03.2016
- URL: https://ogsh.abvpress.ru/jour/article/view/198
- DOI: https://doi.org/10.17650/2222-1468-2016-6-1-43-45
- ID: 198
Cite item
Full Text
Abstract
This paper analyzes the results of treatment for disseminated oral cancer (T1N0M0). The combined (surgery and radiotherapy) treatment group demonstrated the best 5-year overall and relapse-free survival rates (96.6 and 92.3 %, respectively). In the surgery group only, these rates were lower, amounting to 79.2 and 68.7 %, respectively. The medical therapy group was noted to have the lowest 5-year overall and relapse-free survival rates (81.8 and 45.5 %, respectively).
Keywords
About the authors
I. M. Gel’fand
N.N. Blokhin Russian Cancer Research Center at the Ministry of Health of Russia; 24 Kashirskoe Shosse, Moscow, 115478, Russia
Author for correspondence.
Email: igorgelf@yandex.ru
Russian Federation
I. S. Romanov
N.N. Blokhin Russian Cancer Research Center at the Ministry of Health of Russia; 24 Kashirskoe Shosse, Moscow, 115478, Russia
Email: fake@neicon.ru
Russian Federation
D. B. Udintsov
N.N. Blokhin Russian Cancer Research Center at the Ministry of Health of Russia; 24 Kashirskoe Shosse, Moscow, 115478, Russia
Email: fake@neicon.ru
Russian Federation
References
Supplementary files
